Literature DB >> 7920263

Transglutaminase factor XIII uses proteinase-like catalytic triad to crosslink macromolecules.

L C Pedersen1, V C Yee, P D Bishop, I Le Trong, D C Teller, R E Stenkamp.   

Abstract

The X-ray crystal structure of human transglutaminase factor XIII has revealed a cysteine proteinase-like active site involved in a crosslinking reaction and not proteolysis. This is among the first observations of similar active sites in 2 different enzyme families catalyzing a similar reaction in opposite directions. Although the size and overall protein fold of factor XIII and the cysteine proteinases are quite different, the active site and the surrounding protein structure share structural features suggesting a common evolutionary lineage. Here we present a description of the residues in the active site and the structural evidence that the catalytic mechanism of the transglutaminases is similar to the reverse mechanism of the cysteine proteinases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7920263      PMCID: PMC2142901          DOI: 10.1002/pro.5560030720

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  20 in total

1.  Structure of the hirugen and hirulog 1 complexes of alpha-thrombin.

Authors:  E Skrzypczak-Jankun; V E Carperos; K G Ravichandran; A Tulinsky; M Westbrook; J M Maraganore
Journal:  J Mol Biol       Date:  1991-10-20       Impact factor: 5.469

2.  Enzymology. More of the catalytic triad.

Authors:  D Blow
Journal:  Nature       Date:  1990-02-22       Impact factor: 49.962

3.  Calcium-dependent unmasking of active center cysteine during activation of fibrin stabilizing factor.

Authors:  C G Curtis; K L Brown; R B Credo; R A Domanik; A Gray; P Stenberg; L Lorand
Journal:  Biochemistry       Date:  1974-08-27       Impact factor: 3.162

4.  Primary structure of blood coagulation factor XIIIa (fibrinoligase, transglutaminase) from human placenta.

Authors:  N Takahashi; Y Takahashi; F W Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

5.  Alpha-thrombin-catalyzed activation of human platelet factor XIII: relationship between proteolysis and factor XIIIa activity.

Authors:  T J Hornyak; P D Bishop; J A Shafer
Journal:  Biochemistry       Date:  1989-09-05       Impact factor: 3.162

6.  Thiol proteases. Comparative studies based on the high-resolution structures of papain and actinidin, and on amino acid sequence information for cathepsins B and H, and stem bromelain.

Authors:  I G Kamphuis; J Drenth; E N Baker
Journal:  J Mol Biol       Date:  1985-03-20       Impact factor: 5.469

7.  Human factor XIII: fibrin-stabilizing factor.

Authors:  L Lorand; M S Losowsky; K J Miloszewski
Journal:  Prog Hemost Thromb       Date:  1980

8.  Hydrogen bonds involving sulfur atoms in proteins.

Authors:  L M Gregoret; S D Rader; R J Fletterick; F E Cohen
Journal:  Proteins       Date:  1991

Review 9.  Human fibrinogen.

Authors:  J A Shafer; D L Higgins
Journal:  Crit Rev Clin Lab Sci       Date:  1988       Impact factor: 6.250

10.  Contribution of the glutamine 19 side chain to transition-state stabilization in the oxyanion hole of papain.

Authors:  R Ménard; J Carrière; P Laflamme; C Plouffe; H E Khouri; T Vernet; D C Tessier; D Y Thomas; A C Storer
Journal:  Biochemistry       Date:  1991-09-17       Impact factor: 3.162

View more
  33 in total

1.  A superfamily of archaeal, bacterial, and eukaryotic proteins homologous to animal transglutaminases.

Authors:  K S Makarova; L Aravind; E V Koonin
Journal:  Protein Sci       Date:  1999-08       Impact factor: 6.725

2.  Type I transglutaminase accumulation in the endoplasmic reticulum may be an underlying cause of autosomal recessive congenital ichthyosis.

Authors:  Haibing Jiang; Ralph Jans; Wen Xu; Ellen A Rorke; Chen-Yong Lin; Ya-Wen Chen; Shengyun Fang; Yongwang Zhong; Richard L Eckert
Journal:  J Biol Chem       Date:  2010-07-27       Impact factor: 5.157

3.  Identification of eight novel coagulation factor XIII subunit A mutations: implied consequences for structure and function.

Authors:  Vytautas Ivaskevicius; Arijit Biswas; Carville Bevans; Verena Schroeder; Hans Peter Kohler; Hannelore Rott; Susan Halimeh; Petro E Petrides; Harald Lenk; Manuele Krause; Bruno Miterski; Ursula Harbrecht; Johannes Oldenburg
Journal:  Haematologica       Date:  2010-02-23       Impact factor: 9.941

4.  Pasteurella multocida toxin activation of heterotrimeric G proteins by deamidation.

Authors:  Joachim H C Orth; Inga Preuss; Ines Fester; Andreas Schlosser; Brenda A Wilson; Klaus Aktories
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-15       Impact factor: 11.205

5.  Identification of chemical inhibitors to human tissue transglutaminase by screening existing drug libraries.

Authors:  Thung-S Lai; Yusha Liu; Tim Tucker; Kurt R Daniel; David C Sane; Eric Toone; James R Burke; Warren J Strittmatter; Charles S Greenberg
Journal:  Chem Biol       Date:  2008-09-22

6.  Ligand-induced conformational changes in tissue transglutaminase: Monte Carlo analysis of small-angle scattering data.

Authors:  P Mariani; F Carsughi; F Spinozzi; S Romanzetti; G Meier; R Casadio; C M Bergamini
Journal:  Biophys J       Date:  2000-06       Impact factor: 4.033

7.  Glutamine-specific N-terminal amidase, a component of the N-end rule pathway.

Authors:  Haiqing Wang; Konstantin I Piatkov; Christopher S Brower; Alexander Varshavsky
Journal:  Mol Cell       Date:  2009-06-26       Impact factor: 17.970

Review 8.  The N-end rule pathway and regulation by proteolysis.

Authors:  Alexander Varshavsky
Journal:  Protein Sci       Date:  2011-08       Impact factor: 6.725

9.  Crystal structures of protein glutaminase and its pro forms converted into enzyme-substrate complex.

Authors:  Ryota Hashizume; Yukiko Maki; Kimihiko Mizutani; Nobuyuki Takahashi; Hiroyuki Matsubara; Akiko Sugita; Kimihiko Sato; Shotaro Yamaguchi; Bunzo Mikami
Journal:  J Biol Chem       Date:  2011-09-16       Impact factor: 5.157

10.  Evaluating factor XIII specificity for glutamine-containing substrates using a matrix-assisted laser desorption/ionization time-of-flight mass spectrometry assay.

Authors:  Prakash G Doiphode; Marina V Malovichko; Kelly Njine Mouapi; Muriel C Maurer
Journal:  Anal Biochem       Date:  2014-04-19       Impact factor: 3.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.